Taiwanese Upstart Emerges As Threat To Biovail's Wellbutrin XL Patent
Canadian drug maker Biovail Corp. is bracing itself for a legal battle against upstart Taiwanese drug maker Anchen Pharmaceuticals Inc. over patent rights to blockbuster once-daily antidepressant Wellbutrin XL....To view the full article, register now.
Already a subscriber? Click here to view full article